Investigational Drug Information for Hexane-1,6-Diol
✉ Email this page to a colleague
What is the drug development status for Hexane-1,6-Diol?
Hexane-1,6-Diol is an investigational drug.
There have been 6 clinical trials for Hexane-1,6-Diol.
The most recent clinical trial was a Phase 3 trial, which was initiated on June 1st 2012.
The most common disease conditions in clinical trials are Gastritis, Vitamin B 12 Deficiency, and Hypercholesterolemia. The leading clinical trial sponsors are Asofarma de México S.A de C.V., Wanbangde Pharmaceutical Group Co., LTD, and Wanbangde Pharmaceutical Group Limited.
There are one hundred and seven US patents protecting this investigational drug and eleven international patents.
Summary for Hexane-1,6-Diol
| US Patents | 107 |
| International Patents | 11,826 |
| US Patent Applications | 4,034 |
| WIPO Patent Applications | 1,944 |
| Japanese Patent Applications | 23 |
| Clinical Trial Progress | Phase 3 (2012-06-01) |
| Vendors | 83 |
Recent Clinical Trials for Hexane-1,6-Diol
| Title | Sponsor | Phase |
|---|---|---|
| Study on the Pharmacokinetics of Bromine Hexane Hydrochloride Tablets in Healthy Adults | Wanbangde Pharmaceutical Group Co., LTD | Phase 1 |
| Study on the Pharmacokinetics of Bromine Hexane Hydrochloride Tablets in Healthy Adults | Wanbangde Pharmaceutical Group Limited | Phase 1 |
| Study on the Pharmacokinetics of Bromine Hexane Hydrochloride Tablets in Healthy Adults | Second Affiliated Hospital of Wenzhou Medical University | Phase 1 |
Clinical Trial Summary for Hexane-1,6-Diol
Top disease conditions for Hexane-1,6-Diol
Top clinical trial sponsors for Hexane-1,6-Diol
US Patents for Hexane-1,6-Diol
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Hexane-1,6-Diol | See Plans and Pricing | Hair dyeing method employing at least one ortho-diphenol, one titanium derivative and one carboxylic acid | L'Oreal (Paris, FR) | See Plans and Pricing |
| Hexane-1,6-Diol | See Plans and Pricing | Easily formulated zinc oxide powder | BASF SE (Ludwigshafen, DE) | See Plans and Pricing |
| Hexane-1,6-Diol | See Plans and Pricing | Urea derivatives and uses thereof | Kala Pharmaceuticals, Inc. (Waltham, MA) | See Plans and Pricing |
| Hexane-1,6-Diol | See Plans and Pricing | Treatments for resistant acne | VYOME BIOSCIENNCES PVT. LTD. (New Delhi, IN) | See Plans and Pricing |
| Hexane-1,6-Diol | See Plans and Pricing | Polyurea capsule compositions | INTERNATIONAL FLAVORS & FRAGRANCES INC. (New York, NY) | See Plans and Pricing |
| Hexane-1,6-Diol | See Plans and Pricing | Composition containing a cellulose derived capsule with a sunscreen | CoLabs International Corporation (Las Vegas, NV) | See Plans and Pricing |
| Hexane-1,6-Diol | See Plans and Pricing | Foamable composition combining a polar solvent and a hydrophobic carrier | Foamix Pharmaceuticals Ltd. (Rehovot, IL) | See Plans and Pricing |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Hexane-1,6-Diol
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Hexane-1,6-Diol | Australia | AU2014366429 | 2033-12-18 | See Plans and Pricing |
| Hexane-1,6-Diol | Canada | CA2933833 | 2033-12-18 | See Plans and Pricing |
| Hexane-1,6-Diol | China | CN106459737 | 2033-12-18 | See Plans and Pricing |
| Hexane-1,6-Diol | European Patent Office | EP3083873 | 2033-12-18 | See Plans and Pricing |
| Hexane-1,6-Diol | Mexico | MX2016008092 | 2033-12-18 | See Plans and Pricing |
| Hexane-1,6-Diol | Mexico | MX367339 | 2033-12-18 | See Plans and Pricing |
| Hexane-1,6-Diol | World Intellectual Property Organization (WIPO) | WO2015094880 | 2033-12-18 | See Plans and Pricing |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
